SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IPCI
An SI Board Since January 2012
Posts SubjectMarks Bans Symbol
0 0 0 IPCI
Emcee:  Stock Lady Type:  Moderated
Introduction Market Data Compact
IPCI received in Nov 2011 a pre approval for the manufacturing facility. They have 6 drugs in line at the FDA for approval with market size over 6 Billion in branded drugs. Large potential upside as they could be selling drugs in the 4th qtr of this year!!! Large markets. Company focusing on first to file or first to market, If one looks at a comparison of Par Pharmaceuticals who they have a partnership with they have 14 drugs with market size of 6 Billion. Out of those 14 only 4 are not licensed out. A little gem here!!!!
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News